NVIDIA CORPNVIDIA CORP

Institutional investor · Portfolio as of Q2 2026

Top Holdings8 positions

Checking export access…
Activity:

INTEL CORP

214.8M$30B47.3%$36.90+190.19%
3 qtrssince 2025-Q4
Unchanged
0

SPACE EXPLORATION TECHN CORP CLASS A COM STK

122.8M$21B33.1%$170.86-6.02%
1 qtr
New
100

COREWEAVE INC COM CL A

47.2M$4.7B7.4%$56.95+43.24%
6 qtrssince 2025-Q1
Unchanged
0

COHERENT CORP COM

7.8M$3.1B4.8%$280.81+7.67%
2 qtrssince 2026-Q1
Unchanged
0
NOKNOK
ADR

NOKIA CORP SPONSORED ADR

166.4M$2.2B3.5%$6.47+56.72%
3 qtrssince 2025-Q4
Unchanged
0

SYNOPSYS INC

4.8M$2.2B3.4%$469.72+5.97%
3 qtrssince 2025-Q4
Unchanged
0

YANDEX N V

1.2M$328.8M0.5%$26.92+716.16%
7 qtrssince 2024-Q4
Unchanged
0

GENERATE BIOMEDICINES INC COM SHS

833,325$14.1M0.0%$12.50+11.92%
2 qtrssince 2026-Q1
Unchanged
0
$63.4B
AUM
8
Positions
Q2 2026
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+277%Q1'25$1.1B+278%Q2'25$4.3B-11%Q3'25$3.8B+241%Q4'25$13.1B+40%Q1'26$18.4B+245%Q2'26$63.4B
Activity profile
$ moved · Q2'26
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.4 quarters
<1Q13%1-4Q63%1-2Y25%2Y+0%

NVIDIA CORP manages $63.4B across 8 positions as of Q2 2026. Top holdings: INTC (47.3%), SPCX (33.1%), CRWV (7.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q2 2026 Summary

Added 1 new position. Top move: SPCX (NEW, conviction 100). Portfolio: $63.4B across 8 positions.

Top holdings by portfolio weight

Total AUM$63B
INTC47.27%
SPCX33.06%
CRWV7.41%
COHR4.84%
NOK3.48%
SNPS3.39%
NBIS0.52%
GENB0.02%

Portfolio allocation by GICS sector

Sectors2
Technology99.23%
Communication Services0.77%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L93
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used